10X Genomics Stock Forward View - Polynomial Regression
| TXG Stock | USD 18.12 0.61 3.48% |
10X Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of 10X Genomics' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 15th of February 2026 the relative strength index (rsi) of 10X Genomics' share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using 10X Genomics hype-based prediction, you can estimate the value of 10X Genomics from the perspective of 10X Genomics response to recently generated media hype and the effects of current headlines on its competitors.
The Polynomial Regression forecasted value of 10X Genomics on the next trading day is expected to be 16.78 with a mean absolute deviation of 1.17 and the sum of the absolute errors of 71.16. 10X Genomics after-hype prediction price | USD 18.21 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of 10X Genomics to cross-verify your projections. 10X Genomics Additional Predictive Modules
Most predictive techniques to examine 10X price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for 10X using various technical indicators. When you analyze 10X charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
10X Genomics Polynomial Regression Price Forecast For the 16th of February 2026
Given 90 days horizon, the Polynomial Regression forecasted value of 10X Genomics on the next trading day is expected to be 16.78 with a mean absolute deviation of 1.17, mean absolute percentage error of 1.93, and the sum of the absolute errors of 71.16.Please note that although there have been many attempts to predict 10X Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that 10X Genomics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
10X Genomics Stock Forecast Pattern
| Backtest 10X Genomics | 10X Genomics Price Prediction | Research Analysis |
10X Genomics Forecasted Value
In the context of forecasting 10X Genomics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. 10X Genomics' downside and upside margins for the forecasting period are 12.78 and 20.79, respectively. We have considered 10X Genomics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of 10X Genomics stock data series using in forecasting. Note that when a statistical model is used to represent 10X Genomics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.7671 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.1665 |
| MAPE | Mean absolute percentage error | 0.0646 |
| SAE | Sum of the absolute errors | 71.1567 |
Predictive Modules for 10X Genomics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as 10X Genomics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of 10X Genomics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
10X Genomics After-Hype Price Density Analysis
As far as predicting the price of 10X Genomics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in 10X Genomics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of 10X Genomics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
10X Genomics Estimiated After-Hype Price Volatility
In the context of predicting 10X Genomics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on 10X Genomics' historical news coverage. 10X Genomics' after-hype downside and upside margins for the prediction period are 14.21 and 22.21, respectively. We have considered 10X Genomics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
10X Genomics is not too volatile at this time. Analysis and calculation of next after-hype price of 10X Genomics is based on 3 months time horizon.
10X Genomics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as 10X Genomics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading 10X Genomics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with 10X Genomics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.31 | 4.00 | 0.00 | 0.02 | 0 Events / Month | 2 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
18.12 | 18.21 | 0.50 |
|
10X Genomics Hype Timeline
On the 15th of February 2026 10X Genomics is traded for 18.12. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.02. 10X is anticipated to increase in value after the next headline, with the price projected to jump to 18.21 or above. The average volatility of media hype impact on the company the price is insignificant. The price rise on the next news is projected to be 0.5%, whereas the daily expected return is at this time at 0.31%. The volatility of related hype on 10X Genomics is about 6250.0%, with the expected price after the next announcement by competition of 18.10. The company reported the last year's revenue of 642.82 M. Reported Net Loss for the year was (43.54 M) with profit before taxes, overhead, and interest of 442.49 M. Considering the 90-day investment horizon the next anticipated press release will be within a week. Check out Historical Fundamental Analysis of 10X Genomics to cross-verify your projections.10X Genomics Related Hype Analysis
Having access to credible news sources related to 10X Genomics' direct competition is more important than ever and may enhance your ability to predict 10X Genomics' future price movements. Getting to know how 10X Genomics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how 10X Genomics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SDGR | Schrodinger | (0.87) | 9 per month | 0.00 | (0.23) | 3.89 | (5.25) | 21.90 | |
| PGNY | Progyny | 0.00 | 0 per month | 0.00 | (0.17) | 3.51 | (4.17) | 16.49 | |
| GRDN | Guardian Pharmacy Services | 0.00 | 0 per month | 2.28 | 0.09 | 4.55 | (3.61) | 13.96 | |
| TDOC | Teladoc | 0.00 | 0 per month | 0.00 | (0.21) | 4.03 | (4.84) | 15.93 | |
| OMDA | Omada Health Common | 0.00 | 0 per month | 0.00 | (0.21) | 4.61 | (10.52) | 19.12 | |
| JANX | Janux Therapeutics | 0.12 | 7 per month | 0.00 | (0.10) | 7.88 | (5.07) | 63.52 | |
| OMCL | Omnicell | 0.00 | 0 per month | 3.59 | 0.03 | 6.48 | (4.34) | 23.86 | |
| SION | Sionna Therapeutics Common | 0.00 | 0 per month | 5.67 | (0.01) | 7.24 | (8.89) | 31.39 | |
| NUVB | Nuvation Bio | 0.11 | 6 per month | 4.41 | 0.07 | 7.33 | (5.41) | 68.61 | |
| CERT | Certara | 0.00 | 0 per month | 0.00 | (0.13) | 4.75 | (5.06) | 14.22 |
Other Forecasting Options for 10X Genomics
For every potential investor in 10X, whether a beginner or expert, 10X Genomics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. 10X Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in 10X. Basic forecasting techniques help filter out the noise by identifying 10X Genomics' price trends.10X Genomics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 10X Genomics stock to make a market-neutral strategy. Peer analysis of 10X Genomics could also be used in its relative valuation, which is a method of valuing 10X Genomics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
10X Genomics Market Strength Events
Market strength indicators help investors to evaluate how 10X Genomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading 10X Genomics shares will generate the highest return on investment. By undertsting and applying 10X Genomics stock market strength indicators, traders can identify 10X Genomics entry and exit signals to maximize returns.
10X Genomics Risk Indicators
The analysis of 10X Genomics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in 10X Genomics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting 10x stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.99 | |||
| Semi Deviation | 3.25 | |||
| Standard Deviation | 4.0 | |||
| Variance | 16.02 | |||
| Downside Variance | 12.85 | |||
| Semi Variance | 10.59 | |||
| Expected Short fall | (3.39) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for 10X Genomics
The number of cover stories for 10X Genomics depends on current market conditions and 10X Genomics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that 10X Genomics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about 10X Genomics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
10X Genomics Short Properties
10X Genomics' future price predictability will typically decrease when 10X Genomics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of 10X Genomics often depends not only on the future outlook of the potential 10X Genomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. 10X Genomics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 124.7 M | |
| Cash And Short Term Investments | 523.4 M |
Check out Historical Fundamental Analysis of 10X Genomics to cross-verify your projections. For more detail on how to invest in 10X Stock please use our How to Invest in 10X Genomics guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Can Life Sciences Tools & Services industry sustain growth momentum? Does 10X have expansion opportunities? Factors like these will boost the valuation of 10X Genomics. If investors know 10X will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating 10X Genomics demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
The market value of 10X Genomics is measured differently than its book value, which is the value of 10X that is recorded on the company's balance sheet. Investors also form their own opinion of 10X Genomics' value that differs from its market value or its book value, called intrinsic value, which is 10X Genomics' true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because 10X Genomics' market value can be influenced by many factors that don't directly affect 10X Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 10X Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if 10X Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, 10X Genomics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.